Sign in

CIK 0001841387

  • Emerging growth company

Candel Therapeutics, Inc.

Sign in to watch
Ticker
CADL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522214851
Phone
+1 617-916-5445
Business address
117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,160,783
in 1 filing, $3.2M under 10b5-1 plans

Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tak Paul Peter −$3.2M Chief Executive Officer sold 71% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-30 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +2,189 $8.68 $19K 2,189
2026-06-30 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +2,199 $8.64 $19K 2,199
2026-06-23 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +32,000 32,000
2026-03-31 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +4,618 $4.11 $19K 4,618
2026-02-23 Manning Paul B Director Purchase +550,458 $5.45 $3.0M 2,763,527
2025-06-25 Manning Paul B Director Grant or award +1,070,663 $4.67 $5.0M 2,213,069
2025-06-17 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2024-12-16 Manning Paul B Director Purchase +500,000 $6.00 $3.0M 1,142,406
2024-12-16 Manning Paul B Director Purchase +750,000 $6.00 $4.5M 1,303,752
2024-06-26 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2023-06-28 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2022-10-13 Manning Paul B Director Grant or award · Stock Option (Right to Buy) +14,240 14,240
2021-07-29 Manning Paul B Director Conversion +679,158 679,158
2021-07-29 Manning Paul B Director Conversion +553,752 553,752
2021-07-29 Manning Paul B Director Purchase +1,625,000 $8.00 $13.0M 1,681,000
2021-07-29 Manning Paul B Director Conversion · Series B Preferred Stock −1,669,303 0
2021-07-29 Manning Paul B Director Conversion · Series B Preferred Stock −1,361,069 0
2021-07-29 Manning Paul B Director Conversion +679,158 679,158
2021-07-29 Manning Paul B Director Conversion +553,752 553,752
2021-07-29 Manning Paul B Director Conversion · Series B Preferred Stock −1,669,303 0

Page 1 of 2 · 23 trades